Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
Clinical trial NCT04346355 · TERMINATED
Trial details
- NCT number
- NCT04346355
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2020-06-06
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.